Showing 2 of 2 Jobs
Grand Prairie, TX, USA
Full-Time
Confirmed live in the last 24 hours
Data analytics for healthcare and retail solutions
No salary listed
Mid
No H1B Sponsorship
Grand Prairie, TX, USA
This hybrid position requires the associate to work from the Grand Prairie, TX office 3 days a week.
Upload your resume to see how it matches 8 keywords from the job description.
PDF, DOC, DOCX, up to 4 MB
Inmar Intelligence operates at the crossroads of healthcare, retail, and technology, using data analytics to create solutions that improve efficiency and outcomes for patients, healthcare organizations, and consumers. In the healthcare sector, Inmar develops technology-driven solutions that streamline processes and enhance transparency, particularly in healthcare pricing, which helps providers deliver better care while managing costs. In retail and manufacturing, Inmar offers incentive and loyalty solutions that save shoppers money through targeted promotions, leveraging data analytics to understand consumer behavior and tailor offerings. Unlike many competitors, Inmar focuses on providing value-added services that enhance operational efficiency and effectiveness for their clients. Their goal is to drive better outcomes for businesses and consumers by delivering innovative, data-driven solutions.
Company Size
1,001-5,000
Company Stage
N/A
Total Funding
N/A
Headquarters
Winston-Salem, North Carolina
Founded
1980
Help us improve and share your feedback! Did you find this helpful?
Remote Work Options
Hybrid Work Options
WINSTON-SALEM, N.C., April 15, 2025 /PRNewswire/ -- Inmar Intelligence, a leader in healthcare solutions for hospitals, pharmacies and life sciences companies, today announced the successful conclusion of an administrative process with the Drug Enforcement Administration (DEA) through a Memorandum of Agreement. The signing of this agreement affirms Inmar's commitment to stringent regulatory compliance and driving excellence through innovation.Inmar actively collaborated with DEA officials over the last 18 months to reach a shared consensus on the interpretation of controlled substance regulations related to reverse distribution. While this collaborative effort was initiated following the DEA's issuance of an Order to Show Cause, the DEA acknowledged that there was no diversion of controlled substances from any of Inmar's facilities.Inmar's work to assess and implement improvements is ongoing and continued in earnest throughout the conversation with DEA officials. The Agency and Inmar have agreed upon a series of measures that will ensure the company's current standards remain in place while also continuing, in many cases, to exceed regulatory requirements."We are pleased to have concluded this matter with the DEA," said Brian Nightengale, EVP and President, Healthcare at Inmar Intelligence. "This agreement reflects our dedication to not only meeting but exceeding regulatory requirements. Our continuous improvement measures are designed to set new benchmarks in the industry and ensure the highest standards of security and compliance," added Nightengale.Inmar's proactive approach includes the implementation of advanced package-tracking systems, enhanced security protocols, and comprehensive training programs for its employees
MMCAP Infuse members gain automated tools to meet DSCSA requirements and safeguard patient safety. WINSTON-SALEM, N.C., April 9, 2025 /PRNewswire/ -- Inmar Intelligence, a leader in healthcare logistics and compliance solutions, has announced the renewal and expansion of its contract with MMCAP Infuse through a multi-year agreement. This renewed contract extends access to Inmar's comprehensive healthcare solutions while introducing OneRecall®, an advanced recall management system designed to streamline workflows and reduce alert fatigue for healthcare providers. As a national cooperative group purchasing organization (GPO), MMCAP Infuse supports over 34,500 member facilities, including state agencies, counties, cities, school districts, public health facilities, and educational institutions. GPOs like MMCAP Infuse play a critical role in helping their members navigate complex regulatory landscapes, including compliance with the Drug Supply Chain Security Act (DSCSA). However, ensuring full compliance presents operational and logistical challenges, such as standardizing product tracking, managing large networks of suppliers, and implementing efficient recall protocols
Additionally, Upshop is collaborating with key technology partners such as Inmar Intelligence, Vusion Group, STCR, and ResposiTrak to provide insights into the evolving retail landscape and the role of cutting-edge technology in shaping the industry's future.
AD Retail Media elevates in-store advertising with Inmar Intelligence.
Richard Schwabacher, SVP of Healthcare Product at Inmar IntelligenceImagine refilling a prescription, getting real-time health advice, and managing chronic conditions — all with the help of AI. The future of healthcare is here, and it’s powered by artificial intelligence. As AI technology becomes more integrated into healthcare, hospitals and pharmacies are exploring new ways to improve patient outcomes, optimize operations, and ease administrative burdens. AI is also helping the industry address the generational shift in healthcare preferences, where younger consumers expect seamless, automated experiences similar to the digital tools they use in other aspects of their lives. For these patients, AI-driven tools like interactive voice response (IVR) systems act as a “Siri” for healthcare, making it possible to refill prescriptions, get answers, and navigate care options autonomously. Some pharmacies and healthcare providers have already implemented AI-powered voice assistants, reducing call wait times and improving patient access to critical information.AI’s role in clinical and operational settings is expanding rapidly
Simplify Jobs | Apply to Jobs